Principles of tinnitology: Tinnitus diagnosis and treatment a tinnitus-targeted therapy

International Tinnitus Journal

Volumn 16, Issue 1, 2010, Pages 73-85

  Shulman, Abraham ^a   Goldstein, Barbara ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Receptor targeted therapy; Subjective idiopathic tinnitus of the severe disabling type; Tinnitology; Tinnitus targeted therapy

Indexed keywords

BENZODIAZEPINE; CLONAZEPAM; GABAPENTIN;

ALGORITHM; BEDTIME DOSAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG DOSE TITRATION; HUMAN; INSTRUMENTATION; NEUROCHEMISTRY; NUCLEAR MEDICINE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; SURGICAL TECHNIQUE; TINNITUS; TITRIMETRY; VESTIBULOCOCHLEAR NERVE; AUDIOLOGY; DISABILITY; METHODOLOGY;

AUDIOLOGY; DISABILITY EVALUATION; HUMANS; TINNITUS;

EID: 80054775915     PISSN: 09465448     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Shulman A, Goldstein B. Pharmacotherapy for severe disabling tinnitus: 2005-2006. Int Tinnitus J. 2006;(12:2):161-71.
2. Shulman A, Tonndorf J, Feldmann H, et al. Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991.
3. Shulman A. Medical-audiological evaluation of the tinnitus patient. Semin Hear. 1987;8(1):7-14.
4. Shulman A, Goldstein B. Medical significance of tinnitus. Int Tinnitus J. 19973(1):45-50.
5. Shulman A, Goldstein B. Tinnitus dyssynchrony-synchrony theory: A translational concept for diagnosis and treatment and a model for the clinical diagnosis of different clinical type(s) of tinnitus. Int Tinnitus J. 2006;12(2):101-14. (Pubitemid 46043115)
6. Shulman A. Speculations and Conclusions. In A Shulman, J Tonndorf, JM Aran, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991:547.
7. Shulman A. Stress model for tinnitus. Neurotol Newslett. 1998;3(3):53-7.
8. Shulman A. A final common pathway for tinnitus-medial temporal lobe system. Int Tinnitus J. 1995;1:115-26.
9. Shulman A. Medical-Audiologic Tinnitus Patient Protocol. In A Shulman et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991:319-21.
10. Webster's New World Dictionary, 3rd College Edition. New York: Simon & Schuster; 1988.
11. Dorland's Pocket Medical Dictionary, 22nd ed. Philadelphia: WB Saunders; p. 678.
12. Shulman A. Tinnitology, tinnitogenesis nuclear medicine, and tinnitus patients. Int Tinnitus J. 1998;4(2):102-8. (Pubitemid 29447767)
13. Somjen G. Sensory Coding in the Mammalian Nervous System. New York: Appleton-Century-Crofts; 1972.
14. Shulman A. Subjective Clinical Types of Tinnitus. A System of Nomenclature and Classification. In H Feldmann (ed), Proceedings of the Third International Tinnitus Seminar, Munster, 1987. Karlsruhe: Harsch Verlag; 1987:136-41.
15. Shulman A, Aran JM, Tonndorf J, et al. Clinical Types of Tinnitus. In A Shulman, JM Aran, J Tonndorf, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991:323-41, 354-72.
16. Shulman A, Seitz M. Central tinnitus-diagnosis and treatment: Observations of simultaneous auditory brainstem responses with monaural stimulation in the tinnitus patient. Laryngoscope 1981;91:2025-35. (Pubitemid 12205819)
17. Shulman A, Goldstein B, Strashun AM. Central nervous system neurodegeneration and tinnitus: A clinical experience: Part I. Diagnosis. Int Tinnitus J. 2007;13(2):118-31.
18. Shulman A, Goldstein B, Strashun AM. Central nervous system neurodegeneration and tinnitus: A clinical experience: Part II. Translational neurovascular theory of neurodegenerative CNS disease. Int Tinnitus J. 2008;14(1):43-52.
19. Shulman A. Neuroprotective drug therapy: A medical and pharmacological treatment for tinnitus control. Int Tinnitus J. 1997;3(2):77-94.
20. Shulman A, Goldstein B, Strashun AM. Final common pathway for tinnitus: Theoretical and clinical implications of neuroanatomical substrates. Int Tinnitus J. 2009;15(1):5-50.
21. Shulman A, Goldstein B. Subjective idiopathic tinnitus. A review of clinical experience 1979-2005. Otorhinolaryngology 2005;55:23-33. (Pubitemid 40979070)
22. Shulman A, Goldstein B. Subjective idiopathic tinnitus and palliative care: A plan for diagnosis and treatment. Otolaryngol Clin North Am. 2009;42:15-37.
23. Itard JMG. Traite des maladies de l'orielle et de l'audition. Paris; 1821.
24. Shulman A. Clinical Types of Tinnitus. In A Shulman, JM Aran, H Feldmann, et al. (eds), Tinnitus: Diagnosis/Treatment. Philadelphia: Lea & Febiger, 1991:323-41.
25. Landgrebe M, Zeman F, Koller M, et al. The Tinnitus Research Initiative TRI database: A new approach for delineation of tinnitus subtypes and generation of predictors of treatment outcome. BMC Med Informat Decision Making. 2010;10:42. doi:10.1186/1472-6947-10-42.
26. Rothschild G, Nelkon I, MizrahiA: Functional organization and population dynamics in the mouse primary auditory cortex. Nat Neurosci. 2010;13(3):353-60.
27. Andyopadhyay S, Shamma SA, Kanold PO. Dichotomy of functional organization in the mouse auditory cortex. Nat Neurosci. 2010;13(3):361-8.
28. Goldstein B, Shulman A. Tinnitus Evaluation. In J Tonndorf, H Feldmann, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991:293-318.
29. Tonndorf J, Kurman B. High frequency audiometry. Ann Otolaryngol. 1984;93:576-82. (Pubitemid 15154140)
30. Shulman A. Secondary endolymphatic hydrops. Trans Am Acad Otolaryngol Head Neck Surg. 104(1):146-7.
31. Shulman A, Strashun AM. Descending auditory system/cerebellum/tinnitus. Int Tinnitus J. 1999;5(2):92-106. (Pubitemid 30106087)
32. Feldmann H. Homolateral and contralateral masking of tinnitus by noise bands and by pure tones. Audiology. 1971;10:138-44.
33. Shulman A, Goldstein B. Quantitative electroencephalography: Preliminary report-tinnitus. Int Tinnitus J. 2002;8(2):77-86.
34. Shulman A, Strashun AM, et al. Neurospect Cerebral Blood Flow Studies in Patients with a Central Type Tinnitus. In Tinnitus: Proceedings of the Fourth International Tinnitus Seminar. Amsterdam: Kugler Publications; 1991:211-17.
35. Vernon JA. Common Errors in the Use of Masking for Relief of Tinnitus. In A Shulman, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991:50-66.
36. Fritz JB, David SV, Shamma SA, et al. Adaptive, behaviorally gated, persistent encoding of task-relevant auditory information in the ferret frontal cortex. Nat Neurosci. 2010;13(8):1011-9.
37. Shulman A, Strashun AM, Goldstein BA. GABA-A- benzodiazepine-chloride receptor-targeted therapy for tinnitus control: Preliminary report. Int Tinnitus J. 2002; 8(1):30-6. (Pubitemid 34701025)
38. Shulman. A. Specific Etiologies of Tinnitus. In J Tonndorf, H Feldmann, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991:342-415.
39. Shulman A. Tinnitus Treatment. In J Tonndorf, H Feldmann, et al. (eds), Tinnitus Diagnosis/Treatment. Philadelphia: Lea & Febiger; 1991:453-546.
40. Kitahara M. Combined Treatment for Tinnitus. In M Kitahara (ed), Tinnitus, Pathophysiology and Management. Tokyo: Igaku-Shoin, 1988:107-17.
41. Shulman A, Strashun AM. Fluid dynamics vascular theory brain and inner ear function in traumatic brain injury: A translational hypothesis for diagnosis and treatment. Int Tinnitus J. 2009;15(2):119-29.
42. Goddard JC, Berliner K, Luxford W. Recent experience with the neuromonics device. Int Tinnitus J. 2009;15(2):168-73.
43. Shulman A. Instrumentation. In A Shulman, JM Aran, J Tonndorf, H Feldmann, JA Vernon (eds), Tinnitus Diagnosis/Treatment. Malvern, PA: Lea & Febiger; 1991:503-13.
44. Shulman A, Goldstein B. Tinnitus Masking-A Longitudinal Study of Efficacy- Diagnosis: Treatment 1977-1986. In H Feldmann (ed). Proceedings of the Third International Tinnitus Seminar. Karlsruhe: Harsch Verlag; 1987:257-8.
45. Jastreboff PJ, Jastreboff MM. Tinnitus retraining therapy. J Am Acad Audiol 11:162-177, 2000.
46. Choy SJ, Lipman, Tassi, Benedetto del Tronto, AS. Worldwide experience with sequential phase-shift sound cancellation treatment of predominant tone tinnitus. J Laryngol Otol. Jan 2010;13.
47. Goldstein BA, Shulman A, Lenhardt ML, et al. Long-term inhibition of tinnitus by UltraQuiet therapy: Preliminary report. Int Tinnitus J. 2001;7(2):122-7. (Pubitemid 34174366)
48. Langguth B, Zowe M, Landgrabe M, et al. Transcranial magnetic stimulation for the treatment of tinnitus: A new coil positioning method and first results. Brain Topogr. 2006;18:241-7. (Pubitemid 44310322)
49. Shulman A. Transcranial magnetic stimulation: Summary of the Proceedings of the 26th Annual Meeting of the International Tinnitus Forum. Int Tinnitus J. 2009;15(1):62-78.
50. Robinson SK, Viirre ES, Bailey KA, et al. A randomized controlled trial of cognitive behavior therapy for tinnitus. Int Tinnitus J. 2008;14:119-26.
51. Sakata E, Itoh A, Ohtsu K, et al. Treatment of cochlear tinnitus. Effect of transtympanic infusion with dexamethasone fluid. Audiology (Jpn). 1983;26:148-51. (Pubitemid 13074228)
52. Shulman A, Goldstein B. Intratympanic drug therapy with steroids for tinnitus control: A preliminary report. Int Tinnitus J. 2000;6(1):10-20. (Pubitemid 30661106)
53. De Ridder D, De Mulder G, Verstraeten E, et al. Auditory cortex stimulation for tinnitus. Acta Neurochir. 2007;Suppl:97(2):451-62.
54. Van de Heyning P, Anderson I, De Ridder D, et al. Incapacitating unilateral tinnitus in single-sided deafness treated by cochlear implantation. Ann Otol Rhinol Laryngol September 2008.